BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Concord Biotech Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543960
ISIN Demat
INE338H01029
Book Value (Rs)
193.062981
NSE Symbol
CONCORDBIO
Divident Yield %
0.65
Market Cap
(Rs In Cr.)
12,207
P/E (TTM)
45.94
EPS (TTM)
25.4
Face Value
(Rs)
1
Back
Concord Biotech consolidated net profit declines 36.75% in the March 2026 quarter
30-May-26   Hrs IST

Net profit of Concord Biotech declined 36.75% to Rs 88.79 crore in the quarter ended March 2026 as against Rs 140.39 crore during the previous quarter ended March 2025. Sales declined 24.15% to Rs 326.08 crore in the quarter ended March 2026 as against Rs 429.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 29.79% to Rs 260.91 crore in the year ended March 2026 as against Rs 371.64 crore during the previous year ended March 2025. Sales declined 12.10% to Rs 1054.89 crore in the year ended March 2026 as against Rs 1200.09 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales326.08429.88 -24 1054.891200.09 -12
OPM %36.2943.94 -34.8342.08 -
PBDT133.62198.16 -33 422.39548.93 -23
PBT114.08183.54 -38 347.93494.55 -30
NP88.79140.39 -37 260.91371.64 -30

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)